▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Mark Prvulovic

XMFmarkprvulovic

Before joining The Motley Fool, Mark worked as a freelance financial writer covering a variety of markets. Now he spends most of his time researching promising biotech and cannabis stocks, but from time to time will write about whatever catches his interest no matter the industry.

Recent Articles by Mark Prvulovic

GettyImages-1190214200

May 28, 2020 by Mark Prvulovic

Is Natus Medical Stock a Buy?

What should investors think of this infant care and neurology specialist?

GettyImages-1132286331

May 28, 2020 by Mark Prvulovic

Is Teva Pharmaceuticals Stock a Buy?

Is the company's cheap price worth its debt load?

COVID vaccine dollars bills

May 26, 2020 by Mark Prvulovic

Fauci Just Singled Out This Biotech Stock. Is It a Buy?

Out of all the coronavirus vaccine makers on the market, why did Dr. Anthony Fauci call out Moderna?

stock arrow up blue background

May 22, 2020 by Mark Prvulovic

4 Promising Stocks to Own That You Probably Forgot About

These four companies have tremendous growth potential going into 2020.

cannabis plant 2

May 20, 2020 by Mark Prvulovic

Is Aurora Cannabis Finally Making a Recovery?

Are better-than-expected financial results enough to make this recovering pot stock a buy?

safecoinspiggybank

May 6, 2020 by Mark Prvulovic

4 Safe Stocks That Can Make You Rich in This Economy

These four companies are set to make significant gains in the near future.

a person holding a vaccine

May 5, 2020 by Mark Prvulovic

Is Inovio Pharmaceuticals a Buy?

Inovio's become one of the hottest coronavirus-related stocks on the market. But does that make the stock a buy?

biotech microscrope 2

Apr 28, 2020 by Mark Prvulovic

Is Emergent BioSolutions the Next Hot Coronavirus Stock?

With all its new COVID-19 vaccine deals, is this stock worth your attention?

biotech microscrope 2

Apr 21, 2020 by Mark Prvulovic

Is Deciphera Pharmaceuticals a Buy?

What should investors think of this late-stage cancer biotech?

COVID-19 vaccine vial

Apr 21, 2020 by Mark Prvulovic

Will Johnson & Johnson's Coronavirus Vaccine Dominate the Market?

There are many potential coronavirus vaccines out there. Will this one reign supreme?

biotech stock microscope

Apr 16, 2020 by Mark Prvulovic

2 Small-Cap Biotech Stocks You Haven't Heard of, But Should Know About

Keep your eyes on these two stocks in the months to come.

2020 coins savings

Apr 15, 2020 by Mark Prvulovic

4 Dirt-Cheap Dividend Stocks to Buy as the Coronavirus Pandemic Continues

You'd be hard-pressed to find better dividend stocks in the market right now.

COVID-19 test tubes

Apr 11, 2020 by Mark Prvulovic

5 Biotech Stocks Winning the Coronavirus Race

These companies are leading the way with treatments and vaccines for the novel coronavirus.

COVID-19 vial stock market

Apr 11, 2020 by Mark Prvulovic

Will Novavax Make Investors a Fortune?

There's a lot to be excited about regarding this hot biotech stock.

cannabis against a grey background

Apr 9, 2020 by Mark Prvulovic

3 Pot Stocks to Avoid as the Coronavirus Pandemic Continues

Cannabis companies are getting hard hit by the coronavirus. These three companies are getting the worst of it.

abstract medical picture blood cells

Apr 9, 2020 by Mark Prvulovic

Is Alexion Pharmaceuticals a Buy?

Should investors add this biotech stock to their portfolio in 2020?

GettyImages-1028347778

Apr 4, 2020 by Mark Prvulovic

Is CRISPR Therapeutics Stock a Buy?

What should investors think of this well-known gene-editing company?

GettyImages-1050564010

Apr 2, 2020 by Mark Prvulovic

Better Buy: Gilead Sciences vs. Biogen

With everything going on in the markets right now, which of these two biotech stocks is the better investment?

GettyImages-1127504050

Apr 1, 2020 by Mark Prvulovic

Better Buy: Intuitive Surgical vs. Medtronic

Both companies have their pros and cons, but which one will reign supreme in 2020?

GettyImages-1157947296

Apr 1, 2020 by Mark Prvulovic

Top 3 Healthcare Stocks to Buy Right Now

With the coronavirus pandemic pushing stock prices to historic lows, there are plenty of promising companies to invest in today.

HOW THE MOTLEY FOOL CAN HELP YOU

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services